Pavani Chalasani, MD, University of Arizona Cancer Center

Articles by Pavani Chalasani, MD, University of Arizona Cancer Center

Metastatic Triple-Negative Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Metastatic Hormone Epidermal Growth Factor Receptor 2-Positive Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Metastatic Hormone-Receptor Positive Breast Cancer

ByWilliam J. Gradishar, MD, Northwestern University,Priyanka Sharma, MD, University of Kansas Cancer Center,Pavani Chalasani, MD, University of Arizona Cancer Center

January 27th 2021

Latest Updated Articles

Metastatic Hormone Epidermal Growth Factor Receptor 2-Positive Breast Cancer
January 27th 2021
Metastatic Triple-Negative Breast Cancer
January 27th 2021
Metastatic Hormone-Receptor Positive Breast Cancer
January 27th 2021

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

Harold P. Freeman, MD, Pioneer of Patient Navigation and Cancer Disparities Research, Dies at 93